Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action
Danielle H. Bodicoat, Ash Routen, Andrew Willis, et al.
Trials (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England
Yen Yi Tan, Václav Papež, Wai Hoong Chang, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 10, pp. e674-e689
Open Access | Times Cited: 137
Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups—practical guidance to support better practice
Shoba Dawson, Katie Banister, Katie Biggs, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 49
Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
Mayur Murali, Leher Gumber, Hannah Jethwa, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions
Stuart Faulkner, F. Somers, Mathieu Boudes, et al.
Pharmaceutical Medicine (2023) Vol. 37, Iss. 2, pp. 129-138
Open Access | Times Cited: 29
Improving clinical trial design using interpretable machine learning based prediction of early trial termination
Ece Kavalci, Anthony Hartshorn
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Racial and Ethnic Disparities in Primary Prevention of Cardiovascular Disease
Mohammad Ali, Hadjer Nacer, Claire Lawson, et al.
Canadian Journal of Cardiology (2024) Vol. 40, Iss. 6, pp. 1016-1030
Open Access | Times Cited: 10
Primer on Health Equity Research in Health Economics and Outcomes Research: An ISPOR Special Interest Group Report
Mark D. Griffiths, Richard Cookson, Anton L.V. Avanceña, et al.
Value in Health (2025) Vol. 28, Iss. 1, pp. 16-24
Closed Access | Times Cited: 1
Strategies to Optimise the Engagement of Culturally and Linguistically Diverse Populations in Cardiac Research: A Systematic Review
Melissa Abou Chakra, Rebecca Jessup, Alison Beauchamp, et al.
European Journal of Cardiovascular Nursing (2025)
Open Access | Times Cited: 1
How inclusive and representative is research on foster caring in the UK? Findings from a scoping review
Rachael Stemp, Shayma Izzidien, Shivani Sharma, et al.
Adoption & Fostering (2025) Vol. 49, Iss. 1, pp. 7-34
Closed Access | Times Cited: 1
Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis
Ronald Chow, Julie Midroni, Jagdeep Kaur, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 4, pp. 365-374
Open Access | Times Cited: 22
Factors which influence ethnic minority women’s participation in maternity research: A systematic review of quantitative and qualitative studies
Holly Lovell, Sergio A. Silverio, Lisa Story, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0282088-e0282088
Open Access | Times Cited: 18
Enhancing diversity of clinical trial populations in multiple sclerosis
Ruth Ann Marrie, Jeremy Chataway, Barbara E. Bierer, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 9, pp. 1174-1185
Open Access | Times Cited: 18
Barriers and facilitators to the recruitment of disabled people to clinical trials: a scoping review
Sameed Shariq, Alexandra Cardoso Pinto, Shyam Sundar Budhathoki, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Exploring the barriers to, and importance of, participant diversity in early-phase clinical trials: an interview-based qualitative study of professionals and patient and public representatives
Robin Chatters, Munyaradzi Dimairo, Cindy Cooper, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e075547-e075547
Open Access | Times Cited: 6
Preparing for Future Pandemics and Public Health Emergencies: An American College of Physicians Policy Position Paper
Josh Serchen, Katelan Cline, Suja Mathew, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 9, pp. 1240-1244
Closed Access | Times Cited: 14
Improving the inclusion of an under-served group in trials: development and implementation of the INCLUDE Impaired Capacity to Consent Framework
Victoria Shepherd, Katherine Joyce, Amanda Lewis, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Diversity in randomized clinical trials for peripheral artery disease: a systematic review
Chandler A. Long, Abimbola O. Williams, Alysha M. McGovern, et al.
International Journal for Equity in Health (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Disparities in Race and Ethnicity Reporting and Representation for Clinical Trials in Stroke: 2010 to 2020
Hely Nanavati, Mudasir Andrabi, Yurany A. Arevalo, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 5
A toolkit for capturing a representative and equitable sample in health research
Ameeta Retzer, Bircan Ciytak, Foram Khatsuria, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3259-3267
Open Access | Times Cited: 13
Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review
Roger Kou, Sarah Lopes Sadafi, Rachael Principato, et al.
Journal of Clinical Epidemiology (2024) Vol. 169, pp. 111315-111315
Open Access | Times Cited: 4
Training and education on inclusivity in clinical trials—the SENSITISE project
Frances Shiely, Jitka Rychlíčková, Christine Kubiak, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review
Razelle Kurzrock, Aadel A. Chaudhuri, David Feller‐Kopman, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1217-1231
Open Access | Times Cited: 4
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials
Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Paul Kamudoni, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3075-3084
Open Access | Times Cited: 4
Multi-disciplinary fairness considerations in machine learning for clinical trials
Isabel Chien, Nina Deliu, Richard E. Turner, et al.
2022 ACM Conference on Fairness, Accountability, and Transparency (2022), pp. 906-924
Open Access | Times Cited: 17
Evaluating a tool to improve engagement and recruitment of under-served groups in trials
Lydia Morris, Jo C Dumville, Shaun Treweek, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top